The next step: ECDC welcomes decision on new action plan on multi-drug resistant tuberculosisArchived
The WHO Regional Committee for Europe approved a new action plan to tackle multi-drug resistant and extensively drug resistant tuberculosis (M/XDR-TB) today. This is another milestone in the European efforts to secure strong tuberculosis prevention and control across the region.
ECDC has been actively contributing to the new WHO action plan on multi-drug and extensively drug resistant tuberculosis (M/XDR TB) covering the WHO European Region of 53 countries. The plan, as approved by the WHO Regional Committee, takes new diagnostic techniques, patient-centred models of care and services tailored to particular populations into account. The WHO action plan and the ECDC Framework action plan to fight tuberculosis in the European Union complement each other working towards the same goals: reducing the burden of M/XDR-TB and setting clear targets on treatment outcome and diagnosis.
Get the facts: read the ECDC special report “Progressing towards TB elimination”
Download the report “Tuberculosis surveillance in Europe 2009”
Read the ECDC/WHO co-authored article “Tackling the spread of drug-resistant tuberculosis in Europe”
